dual antiplatelet therapy

El Cilostazol disminuye la reestenosis de stents farmacológicos en lesiones de más de 40 mm.

T&iacute;tulo original: Comparison of Dual Versus Triple Antiplatelet Therapy After Drug-Eluting Stent According to Stent Length (from the Pooled Analysis of DECLARE Trials). Referencia: Seung-Whan Lee et al. Am J Cardiol 2013, article in press. &nbsp; El Cilostazol, un inhibidor de la fosfodiesterasa III, asociado a aspirina y clopidogrel demostr&oacute; disminuir la reestenosis angiogr&aacute;fica en<a href="https://solaci.org/2013/10/07/n-3694/" title="Read more" >...</a>

Top